Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TLR4 | O00206 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL16566992 | 1.00 | EPHX2 (0.39) | EPHX2TDP1ALDH1A1TSHRSHBG | |
| Methacrylic Acid SCHEMBL342183 | 1.00 | EPHX2 (0.39) | EPHX2TDP1ALDH1A1TSHRSHBG | |
| Methacrylic Acid SCHEMBL17361257 | 1.00 | EPHX2 (0.39) | EPHX2TDP1ALDH1A1TSHRSHBG | |
| Methacrylic Acid SCHEMBL27635804 | 0.90 | TSHR (0.50) | EPHX2TDP1TSHR | |
| Methacrylic Acid SCHEMBL10645488 | 0.90 | TSHR (0.50) | EPHX2TDP1TSHR | |
| Methacrylic Acid SCHEMBL1048142 | 0.89 | LMNA (0.43) | EPHX2ALDH1A1TSHRLMNA | |
| Methacrylic Acid SCHEMBL23706357 | 0.87 | TSHR (0.48) | EPHX2TDP1ALDH1A1TSHR | |
| Cyclohexanol SCHEMBL30365156 | 0.87 | TSHR (0.48) | EPHX2TDP1ALDH1A1TSHR | |
| Cyclohexanol SCHEMBL3132477 | 0.87 | TSHR (0.48) | EPHX2TDP1ALDH1A1TSHR | |
| Methacrylic Acid SCHEMBL12611395 | 0.87 | KMT2A (0.32) | EPHX2ALDH1A1SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725528-B2 | Process of controlled radical polymerization of branched polyacrylates | Henkel IP & Holding GmbH (DE) | 2017-08-08 | — | — | US | claimed |
| EP-2935348-A1 | PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES | Henkel IP & Holding GmbH (DE) | 2015-10-28 | — | — | EP | claimed |
| US-20150274851-A1 | PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES | HENKEL CORPORATION | 2015-10-01 | — | — | US | claimed |
| US-8912252-B2 | Film-forming pigments and coating system including the same | SILBERLINE MANUFACTURING COMPANY, INC. (US) | 2014-12-16 | — | — | US | claimed |
| WO-2014099748-A1 | PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES | Henkel US IP LLC (US) | 2014-06-26 | — | — | WO | claimed |
| EP-1747059-A1 | PERVAPORATION COMPOSITE MEMBRANES | McMaster University (CA) | 2007-01-31 | — | — | EP | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | claimed |
| EP-4737529-A1 | ADHESIVE COMPOSITION, ADHESIVE TAPE AND THE USE THEREOF, AND METHOD FOR ELECTRICALLY MODIFYING THE ADHESIVE STRENGTH OF THE ADHESIVE TAPE | TESA SE (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12544482-B2 | Antipathogenic compositions | SERVICO GROUP OY (FI) | 2026-02-10 | — | — | US | disclosed |
| US-12338397-B2 | Materials for separating mixtures via selective absorption | UNIVERSITY OF KANSAS (US) | 2025-06-24 | — | — | US | disclosed |
| EP-4531158-A1 | PRESSURE SENSITIVE ADHESIVE ELECTROLYTE | TESA SE (DE) | 2025-04-02 | — | — | EP | disclosed |
| US-12043776-B2 | Pressure sensitive adhesive electrolyte | TESA SE (DE) | 2024-07-23 | — | — | US | disclosed |
| EP-3548103-B1 | ANTIPERSPIRANT DEVICE AND METHOD | UNILEVER IP HOLDINGS B V (NL) | 2024-02-14 | — | — | EP | disclosed |
| US-20100226824-A1 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2010-09-09 | — | — | US | disclosed |
| EP-2226192-A1 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| EP-2226116-A2 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| EP-2226341-A2 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| US-7604746-B2 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2009-10-20 | — | — | US | disclosed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544482-B2 | Antipathogenic compositions | PGD, EBP, ACMSD | EPHX2 1105/4885TDP1 3961/4885ALDH1A1 470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.